Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Desonide (INN) is a low-potency topical corticosteroid anti-inflammatory that has been available since the 1970s. It is primarily used to treat atopic dermatitis (eczema), seborrheic dermatitis, contact dermatitis and psoriasis in both adults and children. It has a fairly good safety profile and is available as a cream, ointment, lotion, and as a foam…
History & Overview
Explore the main themes, entities and connections around Desonide. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
treatment topical patients desonate clinical corticosteroid corticosteroids used effects skin fda anti-inflammatory include mechanism trade names desowen us eczema first
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Desonide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Desonide | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Desonide | ATC code | D07AB08 (WHO) S01BA11 (WHO) | 1.00 | infobox |
| Desonide | CAS Number | 638-94-8 Y | 1.00 | infobox |
| Desonide | ChEBI | CHEBI:204734 Y | 1.00 | infobox |
| Desonide | ChEMBL | ChEMBL1201109 N | 1.00 | infobox |
| Desonide | ChemSpider | 4470603 Y | 1.00 | infobox |
| Desonide | CompTox Dashboard (EPA) | DTXSID7046756 | 1.00 | infobox |
| Desonide | DrugBank | DB01260 Y | 1.00 | infobox |
| Desonide | ECHA InfoCard | 100.010.320 | 1.00 | infobox |
| Desonide | Formula | C24H32O6 | 1.00 | infobox |
| Desonide | IUPHAR/BPS | 7066 | 1.00 | infobox |
| Desonide | KEGG | D03696 Y | 1.00 | infobox |
| Desonide | Legal status | US: ℞-only | 1.00 | infobox |
| Desonide | MedlinePlus | a605025 | 1.00 | infobox |
| Desonide | Molar mass | 416.514 g·mol−1 | 1.00 | infobox |
| Desonide | Other names | Prednacinolone; Hydroxyprednisolone acetonide; Desfluorotriamcinolone acetonide; (11β,16α)-11,21-Dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-pregna-1,4-diene-3,20-dione | 1.00 | infobox |
| Desonide | PubChem CID | 12536 | 1.00 | infobox |
| Desonide | Routes of administration | topical | 1.00 | infobox |
| Desonide | Trade names | Desowen | 1.00 | infobox |
| Desonide | UNII | J280872D1O | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.